The stock of Rockwell Medical Inc (NASDAQ: RMTI) lost 5.03% to close at $0.94. This company speaks out about the continuation of its distribution agreement with Nipro Medical Corporation. The two, take pride in their longstanding working relationship and hope to succeed in their quest to serve patients with dialysate concentrate products for their wellbeing.
Extending the working relationship
Nipro Medical Corporation is quite pleased about the extension of its business collaboration with Rockwell Medical Inc. It states that it will do everything within its means to support the distribution of renal products. Most of the products in question will be channeled to Latin America and the Caribbean to boost supplies in the clinics found in the region. The company considers the region to be an outstanding market opportunity. It hopes to generate higher revenues from the supply of the various products within the region.
Rockwell Medical’s determination
The company has also given projections about what it anticipates in terms of the patients that will be moving in to benefit from the hemodialysis treatment. It promises to join hands with Rockwell Medical for many years to come. It exudes confidence that it might end up achieving massive business success in the region.
Over the years, Rockwell Medical, Inc has expressed an undying determination to spark major transformations in anemia management. It has also achieved a lot in finding working solutions geared towards the treatment of iron deficiency.
The biopharmaceutical company outlines that it will continue with its business collaboration with Nipro Medical Corporation in a bid to improve patient outcomes for persons relying on its wide-ranging products. The terms of the latest deal tie the two companies together for three more years. It implies that the working relationship might extend up to 2014. It was back in 2008 that the two initiated their working agreement.